Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Taxpayers' Cancer Research Funding Act of 2013
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
S.516 PROSTATE Act, H.R. 1293 Taxpayers' Cancer Research Funding Act.
Taxpayers' Cancer Research Funding Act of 2013
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
S. Res 251 S. Res 516 H.R. 1293 S. Res 208 H. Res 348
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2013 · second_quarter · Q2
HR 2143
Labor HHS and Education: Defense Appropriations: Medical Research Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
USPSTF Transparency and Accountability Act of 2013
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
HR 2143
Expressing support for designation of September 2013 as "National Prostate Cancer Awareness Month".
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
S. Res 251 S. Res 516 H.R. 1293 S. Res 208 H. Res 348
S.516 PROSTATE Act, H.R. 1293 Taxpayers' Cancer Research Funding Act.
A resolution designating the week beginning September 8, 2013, as "National Direct Support Professionals Recognition Week".
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
S. Res 251 S. Res 516 H.R. 1293 S. Res 208 H. Res 348
A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for prostate cancer for men in all age groups in consultation with appropriate specialists.
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
S. Res 251 S. Res 516 H.R. 1293 S. Res 208 H. Res 348
A resolution to authorize testimony, document production, and representation in State of North Dakota v. Beatrice Quill.
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
S. Res 251 S. Res 516 H.R. 1293 S. Res 208 H. Res 348
2013 · third_quarter · Q3
S. Res 251 S. Res 516 H.R. 1293 S. Res 208 H. Res 348
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2013 · first_quarter · Q1
S.516 PROSTATE Act, H.R. 1293 Taxpayers' Cancer Research Funding Act.
Continuing Resolution; Defense Appropriations; Labor, Health and Human Services, and Education Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2012 · fourth_quarter · 4A
Appropriations: medical and prostate cancer research; funding for treatment, funding for screening, equal access, access to care and preventive services; the Affordable Care Act, United State Preventative Services Task Force recommendations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2012 · third_quarter · RA
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2012 · third_quarter · RA
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2012 · third_quarter · RA
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care
Cancer research appropriations, funding for treatment, funding for screening, equal access to care